These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2367768)

  • 21. [Anti-HIV-therapy. Monotherapy with drugs delaying the course of the disease has limited effect].
    Julander I; Britton S
    Lakartidningen; 1994 Jul; 91(30-31):2759, 2762-3. PubMed ID: 7520104
    [No Abstract]   [Full Text] [Related]  

  • 22. Lessons from the Concorde trial.
    Peto T; Darbyshire J
    Br J Hosp Med; 1994 Oct 19-Nov 1; 52(8):378-9. PubMed ID: 7858826
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical effectiveness of zidovudine].
    Mulder JW
    Ned Tijdschr Geneeskd; 1995 Feb; 139(5):211-3. PubMed ID: 7854480
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study.
    Ruffault A; Michelet C; Jacquelinet C; Guist'hau O; Genetet N; Bariou C; Colimon R; Cartier F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):243-8. PubMed ID: 7788423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].
    Ugeskr Laeger; 1993 Jan; 155(2):104-7. PubMed ID: 8421854
    [No Abstract]   [Full Text] [Related]  

  • 28. [Early intervention in HIV infection].
    Gotić M; Rolović Z; Elezović I; Marisavljević D; Berger D
    Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():30-2. PubMed ID: 18170974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Several aspects of the treatment of HIV infections].
    Costantino M
    Minerva Med; 1992; 83(1-2):81-2. PubMed ID: 1545928
    [No Abstract]   [Full Text] [Related]  

  • 30. Rage and confusion hide role of HIV.
    Maddox J
    Nature; 1992 May; 357(6375):188-9. PubMed ID: 1589014
    [No Abstract]   [Full Text] [Related]  

  • 31. Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
    Justice AC; Stein DS; Fusco GP; Sherrill BH; Fusco JS; Danehower SC; Becker SL; Hansen NI; Graham NM;
    J Clin Epidemiol; 2004 Jan; 57(1):89-97. PubMed ID: 15019015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical advances in anti-retroviral treatment.
    Ir Med J; 1998; 91(1):30. PubMed ID: 9563258
    [No Abstract]   [Full Text] [Related]  

  • 33. Persistent low plasma levels of HIV-1 in patients on AZT therapy and its implications.
    Camsonne R; Bustany P; Bigot MC; Pottier D; Moulin MA
    Therapie; 1994; 49(2):146-7. PubMed ID: 7817343
    [No Abstract]   [Full Text] [Related]  

  • 34. [Present and future of the antiretroviral therapy].
    Martinez-Vazquez JM; Cabarcos A
    An Med Interna; 1996 Jan; 13(1):1-3. PubMed ID: 8679816
    [No Abstract]   [Full Text] [Related]  

  • 35. [Death and HIV infection].
    Van Vooren JP
    Rev Med Brux; 1998 Feb; 19(1):A37-40. PubMed ID: 9553455
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine.
    Delforge ML; Liesnard C; Debaisieux L; Tchetcheroff M; Farber CM; Van Vooren JP
    AIDS; 1995 Jan; 9(1):89-90. PubMed ID: 7893446
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term prognosis following zidovudine monotherapy in primary human immunodeficiency virus type 1 infection.
    Lindbäck S; Vizzard J; Cooper DA; Gaines H
    J Infect Dis; 1999 Jun; 179(6):1549-52. PubMed ID: 10228080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICAAC 1995: new perspectives on treatment.
    James JS
    AIDS Treat News; 1995 Sep; (no 231):1-2. PubMed ID: 11362866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC; Nielsen C; Gerstoft J; Nielsen CM; Vestergaard BF
    Ugeskr Laeger; 1994 Jan; 156(2):185-6. PubMed ID: 7905217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zidovudine treatment is not associated with HTLV-1 reverse transcriptase gene mutations in HTLV-I/HIV-1 co-infected patients.
    Gasmi M; Fillon S; Leriche K; Neisson-Vernant C; Desgranges C
    Antivir Ther; 1997 Apr; 2(2):91-7. PubMed ID: 11322280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.